Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD

Key Points Given high relapse and CNS involvement of BPDCN, combination chemotherapy and prophylactic CNS-directed therapy are urgently needed. HCVAD chemotherapy plays an important role in the treatment of BPDCN, even in the modern era of CD123-targeted therapy.